Home›Search›Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi
Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi
ABV-press Publishing House · Russian Federation · Est. 2011
ISSN2219-4614
SJR Q4✓ Scopus / SJR
5
/ 100
High Risk
Score Breakdown
✓ Scopus Q4+5
Total5
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.151
H-Index
3
SNIP
0.19
Total Works
155
Total Citations
78
2yr Mean Citedness
0.08
Free JIF alternative
Aims & Scope✦ Compiled from public sources
Sarkomy Kostej, Magkih Tkanej i Opuholi Kozi publishes up-to-date information on scientific clinical research, diagnosis, and treatment of tumors of bones, soft tissues, and skin. The journal aims to increase the professional competence of oncologists and provide a platform for publishing applied and clinical research results.
AI-compiled from public web sources · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2015
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
OncologyQ4
Orthopedics and Sports MedicineQ4
Pathology and Forensic MedicineQ4
Radiology, Nuclear Medicine and ImagingQ4
Subject Classification
Scopus Categories
Radiology, Nuclear Medicine and ImagingOrthopedics and Sports MedicinePathology and Forensic MedicineOncology
Research Topics (OpenAlex)
Sarcoma Diagnosis and TreatmentManagement of metastatic bone diseaseBone Tumor Diagnosis and TreatmentsCutaneous Melanoma Detection and ManagementOrthopaedic implants and arthroplastyCardiac tumors and thrombiVascular Tumors and AngiosarcomasOrthopedic Infections and TreatmentsMelanoma and MAPK PathwaysCAR-T cell therapy research